Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Advances in interleukin-6 therapy].

A Ogata1, N Nishimoto, K Yoshizaki

  • 1Second Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Keratin 15</i> Regulates Cell Proliferation in Outer Enamel Epithelium.

Journal of dental research·2025
Same author

Fragrances as a trigger of immune responses in different environments.

Toxicology in vitro : an international journal published in association with BIBRA·2023
Same author

Integration of Single-Cell RNA- and CAGE-seq Reveals Tooth-Enriched Genes.

Journal of dental research·2021
Same author

Gastrointestinal stromal tumour lacking mutations in the KIT and PDGFRA genes in a cat.

The Journal of small animal practice·2021
Same author

Identification of the Novel Tooth-Specific Transcription Factor AmeloD.

Journal of dental research·2018
Same author

Stim1 Regulates Enamel Mineralization and Ameloblast Modulation.

Journal of dental research·2017

Interleukin-6 (IL-6) is a key regulator of immune responses and cell growth, implicated in diseases like multiple myeloma and rheumatoid arthritis. Neutralizing IL-6 shows promise as a novel therapeutic strategy for these conditions.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Context:

  • Interleukin-6 (IL-6) is a pleiotropic cytokine with critical roles in immune regulation, hematopoiesis, inflammation, and cell growth.
  • The IL-6 receptor complex, comprising IL-6R and gp130, mediates IL-6 signaling through pathways like MAPk and STAT.
  • Other cytokines, including LIF and CNTF, share the gp130 transducer, indicating overlapping biological functions.

Purpose:

  • To elucidate the multifaceted biological activities of Interleukin-6 (IL-6).
  • To describe the IL-6 receptor system and its downstream signaling pathways.
  • To highlight the therapeutic potential of targeting the IL-6 pathway for IL-6-mediated diseases.

Summary:

  • IL-6 drives growth in malignant and non-malignant cells, including plasma cells in multiple myeloma and keratinocytes.

Related Experiment Videos

  • IL-6 is central to inflammatory and immune responses in conditions such as rheumatoid arthritis, Castleman disease, and psoriasis.
  • A humanized anti-IL-6 receptor antibody has been developed, offering a potential therapeutic strategy by neutralizing IL-6 activity.

    • Impact:

    • Understanding IL-6's role is crucial for developing targeted therapies for inflammatory and oncological conditions.
    • The development of anti-IL-6 receptor antibodies opens new avenues for treating IL-6-dependent diseases.
    • This research supports the clinical investigation of IL-6 blockade in autoimmune diseases and cancers.